UNH
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated historical holders
total: 37
Matrix Advisors Value Fund UnitedHealth Group Incorporated transactions over time
- Total transactions:
- 5
- New positions:
- 1
- Added:
- 2
- Reduced:
- 2
- Held since:
- 2023 Q2
- Held for:
- 7 quarters
- Latest activity:
- 2024 Q4
David Katz has been an institutional investor in UnitedHealth Group Incorporated (UNH) since 2023 Q2. According to 2024 Q4 report, David Katz holds 2,600 shares with a market value of roughly $1.32M representing 1.86% of their equity portfolio. The fund/company first acquired UNH in 2023 Q2, initially purchasing 730 shares. Since the initial investment, Matrix Advisors Value Fund has made 4 more transactions in this position.
Does David Katz still hold UNH?
Yes, David Katz continues to hold UnitedHealth Group Incorporated (UNH). According to their 2024 Q4 report, they maintain a position of 2,600 shares valued at approximately $1.32M, representing 1.86% of their equity portfolio.
When did David Katz first invest in UNH?
David Katz first invested in UnitedHealth Group Incorporated (UNH) in 2023 Q2 at the reported quarter-end price of $480.64 per share, acquiring 730 shares in their initial purchase.
What is David Katz's average cost basis for UNH?
Based on historical transaction data, David Katz's estimated cost basis for UnitedHealth Group Incorporated (UNH) is approximately $497.78 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $497.78
- Weighted AVG sell price:
- $512.66
UNH transactions history by Matrix Advisors Value Fund
5 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2024 Q4
|
1.86%
|
2,600
|
$505.86
|
$1,315,236
|
-33.76% (-1,325)
|
-0.97%
|
|
2024 Q3
|
3.32%
|
3,925
|
$584.68
|
$2,294,869
|
-3.09% (-125)
|
-0.11%
|
|
2024 Q1
|
3.09%
|
4,050
|
$494.70
|
$2,003,535
|
+29.60% (+925)
|
+0.71%
|
|
2023 Q3
|
2.94%
|
3,125
|
$504.19
|
$1,575,594
|
+328.08% (+2,395)
|
+2.25%
|
|
2023 Q2
|
0.62%
|
730
|
$480.64
|
$350,867
|
new
|
+0.62%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.